(Press-News.org) A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype (CIMP) status and O 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation as assessed by MGMT-STP27 are the most informative for identifying grade III glioma patients who might benefit from the addition of procarbazine, CCNU and vincristine (PCV) chemotherapy to radiation therapy. Prior results had shown that PCV chemotherapy following standard radiation therapy delayed tumor growth and extended the lives of patients with anaplastic oligodendroglial tumors, a hard-to-treat form of brain cancer.
Results observed in the phase III RTOG 9402 trial, in this case with chemotherapy preceding radiation therapy, complemented the results obtained previously in the EORTC 26951 trial and found that administering both PCV and radiation therapy led to comparable improvements in survival for oligodendroglial tumor patients with specific deletions of genetic material in chromosomes 1p and 19q, but not for patients without the mutation.
Nevertheless up to 30% of oligodendroglial tumors do not have 1p/19q deletion but may still respond to chemotherapy. Analyses of EORTC 26951 and RTOG 9402 suggested that other molecularly defined subsets of grade III tumors might benefit as well.
The new results will be presented at an ASCO 2013 Clinical Science Symposia on Sunday, 02 June 2013 by Dr. Martin J. Van Den Bent of the Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands, and coordinator of the study. According to Dr. Van Den Bent, "This is further evidence pointing towards a central role of methylation in the behavior of IDH (isocitrate dehydrogenase) mutated glioma and, more in general, of the MGMT gene function in glioma when treated with chemotherapy."
Methylation profiles of 115 patients were conducted using Infinium HumanMethylation27 or Infinium HumanMethylation450 BeadChip kits. (Validation in an independent dataset is required.)
In these analyses, two markers, CIMP and MGMT-STP27 methylation status, were considered promising in being able to differentiate between patients who will and will not respond to PCV chemotherapy. Two other markers, IDH mutation status and 1p/19 chromosomal deletion, had less strength in achieving this differentiation.
The EORTC 26951 intergroup trial was coordinated by the EORTC Brain Tumor Group in collaboration with the Medical Research Council Clinical Trial Unit and supported by Stichting STOPhersentumor.nl. This academic trial was activated in August 1996, closed in March 2002, and included 368 patients in 40 sites in 10 countries: Austria, Belgium, Finland, France, Germany, Hungary, Italy, Sweden, The Netherlands, and the United Kingdom.
###
For more information concerning EORTC trial 26951 please contact: http://www.eortc.org/contact
About the EORTC
The European Organisation for the Research and Treatment of Cancer (EORTC) brings together European cancer clinical research experts from all disciplines for trans-national collaboration.
Both multinational and multidisciplinary, the EORTC Network comprises more than 2,500 collaborators from all disciplines involved in cancer treatment and research in more than 300 hospitals in over 30 countries.
Through translational and clinical research, the EORTC offers an integrated approach to drug development, drug evaluation programs and medical practices.
EORTC Headquarters, a unique pan European independent clinical research infrastructure, is based in Brussels, Belgium, from where its various activities are coordinated and run.
EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCV
Results of EORTC trial 26951 presented at ASCO 2013
2013-05-29
ELSE PRESS RELEASES FROM THIS DATE:
Charred micro-bunny sculpture shows promise of new material for 3-D shaping
2013-05-29
Though its surface has been turned to carbon, the bunny-like features can still be easily observed with a microscope. This rabbit sculpture, the size of a typical bacterium, is one of several whimsical shapes created by a team of Japanese scientists using a new material that can be molded into complex, highly conductive 3-D structures with features just a few micrometers across. Combined with state-of-the-art micro-sculpting techniques, the new resin holds promise for making customized electrodes for fuel cells or batteries, as well as biosensor interfaces for medical uses. ...
Despite safety and other concerns, nuclear power saves lives, greenhouse gas emissions
2013-05-29
Global use of nuclear power has prevented about 1.84 million air pollution-related deaths and release of 64 billion tons of greenhouse gases that would have resulted from burning coal and other fossil fuels, a new study concludes. It appears in the ACS journal Environmental Science & Technology.
Pushker A. Kharecha and James E. Hansen state that nuclear power has the potential to help control both global climate change and illness and death associated with air pollution. That potential exists, they say, despite serious questions about safety, disposal of radioactive waste ...
A new addition to the Hall of Fame of science venues
2013-05-29
A building that helped launch generations of scientists, including Nobel laureates, on their careers of discovery has joined the Hall of Fame of notable venues, being named a National Historic Chemical Landmark by the American Chemical Society (ACS).
That's the topic of an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the ACS, the world's largest scientific society.
Susan J. Ainsworth, C&EN senior editor, explains that the ACS recognized the R.B. Wetherill Laboratory of Chemistry building on the Purdue University's ...
New Mayo Clinic approach could lead to blood test to diagnose Alzheimer's in earliest stage
2013-05-29
ROCHESTER, Minn. -- Blood offers promise as a way to detect Alzheimer's disease at its earliest onset, Mayo Clinic researchers say. They envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with the disease -- years before patients begin showing cognitive decline. Their study was recently published online in the journal PLOS ONE.
Researchers analyzed cerebrospinal fluid and plasma samples from 45 people in the Mayo Clinic Study on Aging and Mayo Clinic Alzheimer's Disease Center (15 with no cognitive decline, 15 with mild ...
Study shows longer treatment for children with langerhans cell hystiocytosis improves survival rates
2013-05-29
Washington, DC—A new international study finds that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over the previous clinical trial in this series.
The study, LCH-III, is published in Blood, the journal of the American Society of Hematology. It is the third in a series of international randomized clinical trials for LCH that spans twenty years initiated and coordinated by the Histiocyte Society, a group of more than 200 physicians and ...
Twitter may become less interactive and more an advertising broadcast medium like TV or radio
2013-05-29
PITTSBURGH—Popular social media site Twitter may eventually resemble a broadcast medium like television or radio, with users reading messages written by celebrities and corporations rather than writing their own "tweet" messages of up to 140 characters, suggests a new study coauthored by Andrew T. Stephen, assistant professor of business administration and Katz Fellow in Marketing in the University of Pittsburgh's Joseph M. Katz Graduate School of Business and College of Business Administration.
In one of the first studies to use social media as a laboratory for social ...
People can 'beat' guilt detection tests by suppressing incriminating memories
2013-05-29
New research published by an international team of psychologists has shown that people can suppress incriminating memories and thereby avoid detection in brain activity guilt detection tests.
Such tests, which are commercially available in the USA and are used by law enforcement agencies in several countries, including Japan and India, are based on the logic that criminals will have specific memories of their crime stored in their brain. Once presented with reminders of their crime in a guilt detection test, it is assumed that their brain will automatically and uncontrollably ...
Pigeons peck for computerized treat
2013-05-29
Go to about any public square, and you see pigeons pecking at the ground, always in search of crumbs dropped by a passerby. While the pigeons' scavenging may seem random, new research by psychologists at the University of Iowa suggest the birds are capable of making highly intelligent choices, sometimes with problem-solving skills to match.
The study by Edward Wasserman and colleagues centered on the "string task," a longstanding, standard test of intelligence that involves attaching a treat to one of two strings and seeing if the participant (human or animal) can reel ...
Study finds that radiation oncology research is critically underfunded by NIH
2013-05-29
Radiation oncology research received 197 grants, totaling only 1.6 percent ($85.5 million) of the $5.4 billion in cancer research funding from the National Institutes of Health (NIH) in Fiscal Year (FY) 2013, according to a study available online and in the June 1, 2013, print issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
The study reviewed the more than 50,000 grants funded by the NIH, totaling $30.9 billion. Investigation revealed 952 ...
Brain haemorrhage patients offered better treatment
2013-05-29
An international trial has provided surgeons with a formula which predicts when brain haemorrhage patients need surgery for the best outcome.
Brain haemorrhage affects some 4 million patients a year worldwide and the trial, run from Newcastle University, will help to ensure the best treatment is given at the right time.
David Mendelow, Professor of Neurosurgery at Newcastle University and honorary consultant within the Newcastle Hospitals NHS Foundation Trust, who ran the trials, has devised a formula published today in The Lancet online which will allow surgeons to ...
LAST 30 PRESS RELEASES:
New strategies to enhance chiral optical signals unveiled
Cambridge research uncovers powerful virtual reality treatment for speech anxiety
2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
International survey finds that support for climate interventions is tied to being hopeful and worried about climate change
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Open-Source AI matches top proprietary model in solving tough medical cases
Good fences make good neighbors (with carnivores)
NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer
Introducing our new cohort of AGA Future Leaders
Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help
Engineering excellence: Engineers with ONR ties elected to renowned scientific academy
New CRISPR-based diagnostic test detects pathogens in blood without amplification
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Growing solar: Optimizing agrivoltaic systems for crops and clean energy
Scientists discover how to reactivate cancer’s molecular “kill switch”
YouTube influencers: gaming’s best friend or worst enemy?
uOttawa scientists use light to unlock secret of atoms
NJIT mathematician to help map Earth's last frontier with Navy grant
NASA atmospheric wave-studying mission releases data from first 3,000 orbits
‘Microlightning’ in water droplets may have sparked life on Earth
Smoke from wildland-urban interface fires more deadly than remote wildfires
What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood
Protein accidentally lassos itself, helping explain unusual refolding behavior
With bird flu in raw milk, many in U.S. still do not know risks of consuming it
University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease
UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS
Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it
A closer look at biomolecular ‘silly putty’
Oxytocin system of breastfeeding affected in mothers with postnatal depression
Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles
[Press-News.org] EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCVResults of EORTC trial 26951 presented at ASCO 2013